Related Experiment Video

Updated: Aug 12, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Therapeutic vaccines against melanoma and colorectal cancer

J Tartaglia1, M C Bonnet, N Berinstein

  • 1Aventis Pasteur, Research and Development, Willowdale, Canada.

Vaccine
|March 21, 2001
PubMed

Insights

Researchers are developing novel recombinant vaccines using canarypox virus vectors to stimulate immune responses against melanoma and colorectal cancer. Initial studies show these vaccines are safe and can induce tumor-specific T-cell responses in patients.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Malignant melanoma and colorectal cancer pose significant therapeutic challenges.
  • Developing effective cancer vaccines requires strategies to elicit robust anti-tumor immune responses.
  • Recombinant viral vectors offer a promising platform for vaccine delivery.

Purpose of the Study:

  • To evaluate the safety and immunogenicity of intratumoral administration of recombinant canarypox viruses (ALVAC) carrying cytokine genes in cancer patients.
  • To assess the potential of ALVAC-based vaccines encoding tumor-associated antigens (TAAs) for inducing tumor-specific T-cell responses.
  • To advance the development of multivalent recombinant vaccines for melanoma and colorectal cancer.

Main Methods:

  • Intratumoral administration of recombinant canarypox viruses (ALVAC) encoding cytokine genes.
  • Prime/boost immunization schedules utilizing ALVAC vectors engineered to express TAAs (gp100, Mage 1, Mage 3, p53, CEA).
  • Clinical studies in patients with malignant melanoma and colorectal cancer to evaluate safety and T-cell responses.

Main Results:

  • Intratumoral administration of ALVAC-cytokine vectors was found to be safe in initial patient studies.
  • ALVAC-CEA candidate vaccine studies in colorectal cancer patients demonstrated safety and induced tumor-specific T-cell responses.
  • Ongoing clinical studies are evaluating the efficacy of ALVAC-based vaccines targeting various TAAs in melanoma and colorectal cancer.

Conclusions:

  • Recombinant canarypox virus (ALVAC) vectors are a safe platform for cancer vaccine development.
  • ALVAC-based vaccines can induce tumor-specific T-cell responses in cancer patients.
  • Further clinical evaluation of ALVAC-TAA vaccines is warranted for melanoma and colorectal cancer treatment.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.